Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-26

Clinical Trial Update: Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating indomethacin in combination with a biological therapy for advanced melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biological therapy
  • INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: St. Luke's Medical Center | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED